Will Yeast Lead The Way To Parkinson’s Disease Drugs? An Interview With Tony Coles Of Yumanity Therapeutics
This article was originally published in Start Up
Executive Summary
The duo behind Yumanity brings to it multiple successes measured by basic science discoveries, new drugs for patients, and billions made for investors. Can they do it again with their novel approach for discovering neurodegenerative disease drugs?